KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases.
Margonis GA, Amini N, Andreatos N, Sasaki K, McVey J, Mirza MB, Warner S, Buettner S, Barbon C, Wang J, Pulvirenti A, Angelou A, Kamphues C, Antoniou E, Pikoulis E, Pawlik TM, Kaczirek K, Poultsides G, Wagner D, Endo I, Imai K, Aucejo F, Kreis ME, Wolfgang CL, Weiss MJ.
Margonis GA, et al. Among authors: wolfgang cl.
HPB (Oxford). 2019 Nov;21(11):1527-1534. doi: 10.1016/j.hpb.2019.03.368. Epub 2019 Apr 9.
HPB (Oxford). 2019.
PMID: 30979646
Free article.